Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2003

View Archived Issues

CX-659S prevents rebound after prednisolone treatment

Effective use of sumatriptan in OCD

Good efficacy and safety profile established for atlizumab in rheumatoid arthritis

Antitumor effects described for SU-11654 in spontaneous canine tumors

Potential of levetiracetam in neuropathic pain

Genta acquires license to siRNA

Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial

Fougera's lidocaine/prilocaine cream approved by FDA

NicOx and Merck sign research evaluation agreement for nitric oxide-donating drugs

IND filed for Atrigel formulation of octreotide

Fast track designation awarded to ABthrax

Merck & Co. discontinues development of first Karo Bio collaboration compound

Phase I bridging study of LEP-ETU commences

Levitra receives FDA approval

Thalidomide recommended for approval in Australia

Priority review for Vitrase NDA

Janssen patent covers prucalopride N-oxide isomers and their use

New acetylcholine receptor modulators in early development at Merck KGaA

Axovan scientists present novel antiobesity NPY Y5 antagonists

New PARP inhibitors and their use in ischemia-reperfusion injury

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...